SE7604052L - Nya erytromycinderivat och forfarande for framstellning derav - Google Patents

Nya erytromycinderivat och forfarande for framstellning derav

Info

Publication number: SE7604052L
Authority: SE; Sweden
Prior art keywords: procedures; manufacture; erythromycin derivatives; new erythromycin; new
Prior art date: 1975-04-07

Application number

SE7604052A

Other languages

English (en)

Other versions

SE425566B (sv

Inventor

R Maier

E Woitun

B Wetzel

W Reuter

H Goeth

U Lechner

Original Assignee

Thomae Gmbh Dr K

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1975-04-07

Filing date

1976-04-06

Publication date

1976-10-08

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25768725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE7604052(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1975-04-07 Priority claimed from DE2515075A external-priority patent/DE2515075C2/de

1976-02-14 Priority claimed from DE19762606030 external-priority patent/DE2606030A1/de

1976-04-06 Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K

1976-10-08 Publication of SE7604052L publication Critical patent/SE7604052L/sv

1982-10-11 Publication of SE425566B publication Critical patent/SE425566B/sv

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65586—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system at least one of the hetero rings does not contain nitrogen as ring hetero atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Communicable Diseases (AREA)
Saccharide Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SE7604052A 1975-04-07 1976-04-06 Forfarande for framstellning av erytromycinderivat och syraadditionssalter derav SE425566B (sv)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE2515075A DE2515075C2 (de)	1975-04-07	1975-04-07	Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19762606030 DE2606030A1 (de)	1976-02-14	1976-02-14	Neue erythromycinderivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number	Publication Date
SE7604052L true SE7604052L (sv)	1976-10-08
SE425566B SE425566B (sv)	1982-10-11

Family

ID=25768725

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7604052A SE425566B (sv)	1975-04-07	1976-04-06	Forfarande for framstellning av erytromycinderivat och syraadditionssalter derav

Country Status (29)

Country	Link
US (1)	US4048306A (sv)
JP (1)	JPS51128991A (sv)
AT (1)	AT342770B (sv)
AU (1)	AU498418B2 (sv)
BG (1)	BG27380A3 (sv)
CA (1)	CA1060005A (sv)
CH (2)	CH621800A5 (sv)
CS (1)	CS196304B2 (sv)
DD (1)	DD125218A5 (sv)
DK (1)	DK138656C (sv)
ES (2)	ES446737A1 (sv)
FI (1)	FI63244C (sv)
FR (1)	FR2306703A1 (sv)
GB (1)	GB1520963A (sv)
GR (1)	GR60374B (sv)
HU (1)	HU175186B (sv)
IE (1)	IE43598B1 (sv)
IL (1)	IL49359A (sv)
LU (2)	LU88563I2 (sv)
MX (1)	MX3277E (sv)
NL (1)	NL180107C (sv)
NO (1)	NO141411C (sv)
NZ (1)	NZ180529A (sv)
PL (1)	PL101880B1 (sv)
PT (1)	PT64977B (sv)
RO (1)	RO68441B (sv)
SE (1)	SE425566B (sv)
SU (1)	SU682134A3 (sv)
YU (1)	YU87676A (sv)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO860901L (no)	1985-03-12	1986-09-15	Beecham Group Plc	Fremgangsmaate for fremstilling av farmasoeytisk aktive erytromycinderivater.
DE3524572A1 (de) *	1985-07-10	1987-01-15	Thomae Gmbh Dr K	Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
US5110800A (en) *	1986-02-18	1992-05-05	Eli Lilly And Company	Derivatives of erythromycylamine
US4945080A (en) *	1987-05-26	1990-07-31	Eli Lilly And Company	Dirithromycin metabolite
US5075289A (en) *	1988-06-07	1991-12-24	Abbott Laboratories	9-r-azacyclic erythromycin antibiotics
US5403923A (en) *	1990-11-28	1995-04-04	Taisho Pharmaceutical Co., Ltd.	6-0-methylerythromycin A derivatives
ZA922776B (en) *	1991-04-29	1993-10-15	Lilly Co Eli	Pharmaceutical compounds
US5556839A (en) *	1991-04-29	1996-09-17	Eli Lilly And Company	Form II Dirithromycin
SK279270B6 (sk) *	1991-09-30	1998-08-05	Eli Lilly And Company Patent Division Lilly Corpor	Spôsob jednostupňovej prípravy diritromycínu
US5527780A (en) *	1992-11-05	1996-06-18	Roussel Uclaf	Erythromycin derivatives
DE4410637C1 (de) *	1994-03-26	1995-09-21	Boehringer Ingelheim Vetmed	Injizierbare Lösungen von Dirithromycin
FR2718450B1 (fr) *	1994-04-08	1997-01-10	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) *	1994-05-03	1996-07-12	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
WO1999021867A1 (fr) *	1997-10-29	1999-05-06	Taisho Pharmaceutical Co., Ltd.	Derives d'erythromycine a
US6544555B2 (en)	2000-02-24	2003-04-08	Advancis Pharmaceutical Corp.	Antibiotic product, use and formulation thereof
US6565882B2 (en)	2000-02-24	2003-05-20	Advancis Pharmaceutical Corp	Antibiotic composition with inhibitor
US6541014B2 (en)	2000-10-13	2003-04-01	Advancis Pharmaceutical Corp.	Antiviral product, use and formulation thereof
US20020068078A1 (en)	2000-10-13	2002-06-06	Rudnic Edward M.	Antifungal product, use and formulation thereof
US6436906B1 (en)	2001-04-02	2002-08-20	Enanta Pharmaceuticals, Inc.	9-amino-14-membered macrolides derived from leucomycins
CA2533178C (en)	2003-07-21	2014-03-11	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
US8313775B2 (en)	2003-07-21	2012-11-20	Shionogi Inc.	Antibiotic product, use and formulation thereof
US8425936B2 (en)	2003-07-21	2013-04-23	Shionogi Inc.	Antibiotic product, use and formulation thereof
JP2007502296A (ja)	2003-08-11	2007-02-08	アドバンシスファーマスーティカルコーポレイション	ロバストペレット
CA2535398C (en)	2003-08-12	2013-11-12	Advancis Pharmaceuticals Corporation	Antibiotic product, use and formulation thereof
AU2004270170B2 (en) *	2003-08-29	2011-01-27	Shionogi, Inc.	Antibiotic product, use and formulation thereof
WO2005027877A1 (en)	2003-09-15	2005-03-31	Advancis Pharmaceutical Corporation	Antibiotic product, use and formulation thereof
WO2006014427A1 (en)	2004-07-02	2006-02-09	Advancis Pharmaceutical Corporation	Tablet for pulsed delivery
US8357394B2 (en)	2005-12-08	2013-01-22	Shionogi Inc.	Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en)	2006-12-04	2014-07-15	Shionogi Inc.	Modified release amoxicillin products
US8299052B2 (en) *	2006-05-05	2012-10-30	Shionogi Inc.	Pharmaceutical compositions and methods for improved bacterial eradication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3660376A (en) *	1970-09-30	1972-05-02	Lilly Co Eli	N-arylidene erythromycylamines

1976
- 1976-03-01 AT AT149976A patent/AT342770B/de not_active IP Right Cessation
- 1976-03-26 GR GR50399A patent/GR60374B/el unknown
- 1976-03-29 US US05/671,421 patent/US4048306A/en not_active Expired - Lifetime
- 1976-03-29 BG BG032727A patent/BG27380A3/xx unknown
- 1976-03-30 DK DK145276A patent/DK138656C/da not_active IP Right Cessation
- 1976-03-30 FI FI760845A patent/FI63244C/fi not_active IP Right Cessation
- 1976-04-02 CH CH417476A patent/CH621800A5/de not_active IP Right Cessation
- 1976-04-05 DD DD192208A patent/DD125218A5/xx unknown
- 1976-04-05 LU LU88563C patent/LU88563I2/fr unknown
- 1976-04-05 LU LU74702A patent/LU74702A1/xx unknown
- 1976-04-06 SE SE7604052A patent/SE425566B/sv not_active IP Right Cessation
- 1976-04-06 PT PT64977A patent/PT64977B/pt unknown
- 1976-04-06 HU HU76TO1026A patent/HU175186B/hu unknown
- 1976-04-06 CA CA249,700A patent/CA1060005A/en not_active Expired
- 1976-04-06 MX MX000145U patent/MX3277E/es unknown
- 1976-04-06 NL NLAANVRAGE7603569,A patent/NL180107C/xx not_active IP Right Cessation
- 1976-04-06 NO NO761172A patent/NO141411C/no unknown
- 1976-04-06 NZ NZ180529A patent/NZ180529A/xx unknown
- 1976-04-06 RO RO85433A patent/RO68441B/ro unknown
- 1976-04-06 JP JP51038681A patent/JPS51128991A/ja active Granted
- 1976-04-06 AU AU12722/76A patent/AU498418B2/en not_active Expired
- 1976-04-06 ES ES446737A patent/ES446737A1/es not_active Expired
- 1976-04-06 CS CS762265A patent/CS196304B2/cs unknown
- 1976-04-06 SU SU762343016A patent/SU682134A3/ru active
- 1976-04-06 YU YU00876/76A patent/YU87676A/xx unknown
- 1976-04-06 PL PL1976188538A patent/PL101880B1/pl unknown
- 1976-04-06 IL IL49359A patent/IL49359A/xx unknown
- 1976-04-06 GB GB13942/76A patent/GB1520963A/en not_active Expired
- 1976-04-07 IE IE732/76A patent/IE43598B1/en not_active IP Right Cessation
- 1976-04-07 FR FR7610144A patent/FR2306703A1/fr active Granted
1977
- 1977-03-05 ES ES456567A patent/ES456567A1/es not_active Expired
1980
- 1980-04-10 CH CH277580A patent/CH624413A5/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
ES446737A1 (es)	1977-10-16
FI760845A7 (sv)	1976-10-08
FR2306703B1 (sv)	1979-10-12
IE43598L (en)	1976-10-07
AT342770B (de)	1978-04-25
NO141411C (no)	1980-03-05
AU1272276A (en)	1977-10-13
NL7603569A (nl)	1976-10-11
JPS51128991A (en)	1976-11-10
PT64977A (de)	1976-05-01
MX3277E (es)	1980-08-15
JPS62158B2 (sv)	1987-01-06
PL101880B1 (pl)	1979-02-28
US4048306A (en)	1977-09-13
SU682134A3 (ru)	1979-08-25
NL180107B (nl)	1986-08-01
LU88563I2 (fr)	1995-03-21
CS196304B2 (en)	1980-03-31
SE425566B (sv)	1982-10-11
ES456567A1 (es)	1978-03-01
LU74702A1 (sv)	1977-06-03
RO68441B (ro)	1983-04-30
IL49359A (en)	1979-07-25
AU498418B2 (en)	1979-03-15
DK145276A (da)	1976-10-08
DK138656B (da)	1978-10-09
NO761172L (sv)	1976-10-08
FI63244B (fi)	1983-01-31
IL49359A0 (en)	1976-06-30
NO141411B (no)	1979-11-26
NZ180529A (en)	1978-09-20
FR2306703A1 (fr)	1976-11-05
FI63244C (fi)	1983-05-10
BG27380A3 (bg)	1979-10-12
DD125218A5 (de)	1977-04-06
HU175186B (hu)	1980-05-28
PT64977B (de)	1978-04-03
RO68441A (ro)	1983-04-29
GB1520963A (en)	1978-08-09
CH624413A5 (sv)	1981-07-31
CA1060005A (en)	1979-08-07
YU87676A (en)	1982-08-31
GR60374B (en)	1978-05-23
IE43598B1 (en)	1981-04-08
DK138656C (da)	1979-04-02
NL180107C (nl)	1987-01-02
ATA149976A (de)	1977-08-15
CH621800A5 (sv)	1981-02-27

Publication	Publication Date	Title
SE7604052L (sv)	1976-10-08	Nya erytromycinderivat och forfarande for framstellning derav
SE7612366L (sv)	1977-05-08	Nya hydroxibensylmalonsyra-derivat.
SE416298B (sv)	1980-12-15	Forfarande for framstellning av nya bensimidazolinon derivat
ES434533A1 (es)	1976-12-01	Un procedimiento para la preparacion de compuestos tetraci-clicos.
ES466851A1 (es)	1978-10-01	Procedimiento para la preparacion de 2-bromo-6-fluor-n-2- imidazolidinilidenbenzamina.
ES462173A1 (es)	1978-06-16	Procedimiento para la preparacion de derivados de acido 7-a-cilamino-8-oxo-3-oxa-1-azabiciclo-(4,2,0)-octan-2-carboxili-co.
SE7411243L (sv)	1975-05-02
SE7609495L (sv)	1977-02-28	N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
ES428005A1 (es)	1976-07-16	Procedimiento para la preparacion de derivados de 3-4-dihi-dro-2h-naftalenom-(1)-5-oxi-propil-piperazina.
MX4655E (es)	1982-07-19	Procedimiento para preparar derivados del acido 3,3,'-triarilmetanodicarboxilico
ES449688A1 (es)	1977-11-16	Procedimiento para la preparacion de un acido 7-(alfa-amino-w-(3, 4-metilenodioxifenil) acilamido) cefalosporanico.
ES462849A1 (es)	1978-06-01	Un procedimiento para la preparacion de nuevos derivados de 3,5-diona-4,4-dimetil-pirrolidina.
SE7512857L (sv)	1976-05-24	Nya konoaxalin-1,4-dioxidderivat jemte sett for deras framstellning
ES449991A1 (es)	1977-12-01	Procedimiento para la preparacion de derivados de acido 7 (alfaamino-omega-(2,3-metilenodioxifenil y acilamido) cefa- losporanico.
SE7606318L (sv)	1976-12-06	Nya tienyl-prostaglandiner och forfarande for deras framstellning
ZA761859B (en)	1977-03-30	Novel substituted sulfonamide derivatives as anthelmintic agents
AR219072A1 (es)	1980-07-31	Procedimiento para preparar nuevos derivados de(piridil-3-imino)-3-tetrahidro 1,5,10,10a-tiazol(3,4-b)-isoquinoleina
BE848118A (fr)	1977-05-09	Procede de production d'un compose extincteur,
AR212431A1 (es)	1978-07-14	Procedimiento para obtener derivados de 1-sulfonilbecimidazol 2,5(6)sustituidos
AR212174A1 (es)	1978-05-31	Procedimiento para la preparacion de derivados de las 1-aminometil-6,7-dihidroxi-1,2,3,4-tetrahidroisoquinoleinas
SE7601097L (sv)	1976-11-28	Piperidinderivat
IT1055240B (it)	1981-12-21	Procedimento per la produzione di composizioni antitraspiranti
ES428823A1 (es)	1976-08-16	Procedimiento para la preparacion de derivados de adenosinadisustituidos en n(6).
BE842740A (fr)	1976-10-01	Procede de preparation de derives de substitution de la 1,2,4 oxadiazoline-3-one
AR210879A1 (es)	1977-09-30	Procedimiento de preparacion de derivados de acido 2,3-dioxo-1-piperazinocarboinil-amion -cecefem-4-carboxilico

Legal Events

Date	Code	Title	Description
1995-01-31	NAL	Patent in force	Ref document number: 7604052-6 Format of ref document f/p: F
1996-07-01	NUG	Patent has lapsed	Ref document number: 7604052-6 Format of ref document f/p: F

Date

Code

Title

Description

1995-01-31

NAL

Patent in force

Ref document number: 7604052-6

Format of ref document f/p: F

1996-07-01

NUG

Patent has lapsed